microRNA和lncRNA在银屑病中的研究进展

doi:10.3760/cma.j.issn.0412-4030.2019.05.016

Abstract

Abstract: 【Abstract】 Psoriasis is a common chronic inflammatory skin disease, and commonly considered as a T cell?mediated abnormal immune disease with genetic predisposition at present. Recent studies have indicated that microRNA and lncRNA play important roles in occurrence and development of a variety of inflammatory immune diseases. It has been confirmed that microRNA and lncRNA participate in the occurrence of psoriasis by regulating the proliferation and differentiation of keratinocytes, release of inflammatory factors, and angiopoiesis. This review summarizes research advances in roles of microRNA and lncRNA in psoriasis.

Key words: Psoriasis, MicroRNAs, LncRNAs

Hu Yu, Chen Min, Gu Heng. MicroRNA and lncRNA in psoriasis[J].Chinese Journal of Dermatology, 2019, 52(5): 350-353.

References ［36］

［1］	Nestle FO, Kaplan DH, Barker J. Psoriasis［J］. N Engl J Med, 2009,361（5）:496⁃509. doi: 10.1056/NEJMra0804595.
［2］	Wang J, Song YX, Wang ZN. Non⁃coding RNAs in gastric cancer［J］. Gene, 2015,560（1）:1⁃8. doi: 10.1016/j.gene.2015.02. 004.
［3］	Deng X, Su Y, Wu H, et al. The role of microRNAs in autoimmune diseases with skin involvement［J］. Scand J Immunol, 2015,81（3）:153⁃165. doi: 10.1111/sji.12261.
［4］	Sonkoly E, Wei T, Janson PC, et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis?［J/OL］. PLoS One, 2007,2（7）:e610. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC 1905940/. doi: 10.1371/journal.pone.0000610.
［5］	Xu Y, Ji Y, Lan X, et al. miR⁃203 contributes to IL⁃17⁃induced VEGF secretion by targeting SOCS3 in keratinocytes［J］. Mol Med Rep, 2017,16（6）:8989⁃8996. doi: 10.3892/mmr.2017.7759.
［6］	Primo MN, Bak RO, Schibler B, et al. Regulation of pro⁃inflammatory cytokines TNFα and IL24 by microRNA⁃203 in primary keratinocytes［J］. Cytokine, 2012,60（3）:741⁃748. doi: 10.1016/j.cyto.2012.07.031.
［7］	Wei T, Xu N, Meisgen F, et al. Interleukin⁃8 is regulated by miR⁃203 at the posttranscriptional level in primary human keratinocytes［J/OL］. Eur J Dermatol, 2013. ［2018⁃04⁃02］. https://www.jle.com/fr/revues/ejd/e⁃docs/interleukin_8_is_regulated_by_mir_203_at_the_posttranscriptional_level_in_primary_human_keratinocytes_296259/article.phtml. doi: 10.1684/ejd.2013.1997.
［8］	Meisgen F, Xu Landén N, Wang A, et al. MiR⁃146a negatively regulates TLR2⁃induced inflammatory responses in keratino⁃cytes［J］. J Invest Dermatol, 2014,134（7）:1931⁃1940. doi: 10. 1038/jid.2014.89.
［9］	Hermann H, Runnel T, Aab A, et al. MiR⁃146b probably assists miRNA⁃146a in the suppression of keratinocyte proliferation and inflammatory responses in psoriasis［J］. J Invest Dermatol, 2017,137（9）:1945⁃1954. doi: 10.1016/j.jid.2017.05.012.
［10］	Srivastava A, Nikamo P, Lohcharoenkal W, et al. MicroRNA⁃146a suppresses IL⁃17⁃mediated skin inflammation and is genetically associated with psoriasis［J］. J Allergy Clin Immunol, 2017,139（2）:550⁃561. doi: 10.1016/j.jaci.2016.07.025.
［11］	Meisgen F, Xu N, Wei T, et al. MiR⁃21 is up⁃regulated in psoriasis and suppresses T cell apoptosis［J］. Exp Dermatol, 2012,21（4）:312⁃314. doi: 10.1111/j.1600⁃0625.2012.01462.x.
［12］	Guinea⁃Viniegra J, Jiménez M, Schonthaler HB, et al. Targeting miR⁃21 to treat psoriasis［J］. Sci Transl Med, 2014,6（225）:225re1. doi: 10.1126/scitranslmed.3008089.
［13］	Xu N, Meisgen F, Butler LM, et al. MicroRNA⁃31 is over⁃expressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40［J］. J Immunol, 2013,190（2）:678⁃688. doi: 10.4049/jimmunol.1202695.
［14］	Yan S, Xu Z, Lou F, et al. NF⁃κB⁃induced microRNA⁃31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis［J］. Nat Commun, 2015,6:7652. doi: 10.1038/ncomms8652.
［15］	Borska L, Andrys C, Chmelarova M, et al. Roles of miR⁃31 and endothelin⁃1 in psoriasis vulgaris: pathophysiological functions and potential biomarkers［J］. Physiol Res, 2017,66（6）:987⁃992.
［16］	Xu L, Leng H, Shi X, et al. MiR⁃155 promotes cell proliferation and inhibits apoptosis by PTEN signaling pathway in the psoriasis［J］. Biomed Pharmacother, 2017,90:524⁃530. doi: 10. 1016/j.biopha.2017.03.105.
［17］	Hou RX, Liu RF, Zhao XC, et al. Increased miR⁃155⁃5p in dermal mesenchymal stem cells of psoriatic patients: comparing the microRNA profile by microarray［J］. Genet Mol Res, 2016,15（3）. doi: 10.4238/gmr. 15038631.
［18］	Xu N, Brodin P, Wei T, et al. MiR⁃125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2［J］. J Invest Dermatol, 2011,131（7）:1521⁃1529. doi: 10.1038/jid.2011.55.
［19］	Wei T, Folkersen L, Biskup E, et al. Ubiquitin⁃specific peptidase 2 as a potential link between microRNA⁃125b and psoriasis［J］. Br J Dermatol, 2017,176（3）:723⁃731. doi: 10.1111/bjd.14916.
［20］	Jiang M, Sun Z, Dang E, et al. TGFβ/SMAD/microRNA⁃486⁃3p signaling axis mediates keratin 17 and keratinocyte hyperproliferation in psoriasis［J］. J Invest Dermatol, 2017,137（10）:2177⁃2186. doi: 10.1016/j.jid.2017.06.005.
［21］	Ichihara A, Jinnin M, Yamane K, et al. microRNA⁃mediated keratinocyte hyperproliferation in psoriasis vulgaris［J］. Br J Dermatol, 2011,165（5）:1003⁃1010. doi: 10.1111/j.1365⁃2133. 2011.10497.x.
［22］	Chowdhari S, Sardana K, Saini N. miR⁃4516, a microRNA downregulated in psoriasis inhibits keratinocyte motility by targeting fibronectin/integrin α9 signaling［J］. Biochim Biophys Acta Mol Basis Dis, 2017,1863（12）:3142⁃3152. doi: 10.1016/j.bbadis.2017.08.014.
［23］	St Laurent G, Wahlestedt C, Kapranov P. The Landscape of long noncoding RNA classification［J］. Trends Genet, 2015,31（5）:239⁃251. doi: 10.1016/j.tig.2015.03.007.
［24］	Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs［J］. Mol Cell, 2011,43（6）:904⁃914. doi: 10.1016/j.molcel. 2011.08.018.
［25］	Tsoi LC, Iyer MK, Stuart PE, et al. Analysis of long non⁃coding RNAs highlights tissue⁃specific patterns and epigenetic profiles in normal and psoriatic skin［J］. Genome Biol, 2015,16:24. doi: 10.1186/s13059⁃014⁃0570⁃4.
［26］	Ahn R, Gupta R, Lai K, et al. Network analysis of psoriasis reveals biological pathways and roles for coding and long non⁃coding RNAs［J］. BMC Genomics, 2016,17（1）:841. doi: 10.1186/ s12864⁃016⁃3188⁃y.
［27］	Gupta R, Ahn R, Lai K, et al. Landscape of long noncoding RNAs in psoriatic and healthy skin［J］. J Invest Dermatol, 2016,136（3）:603⁃609. doi: 10.1016/j.jid.2015.12.009.
［28］	Szegedi K, Göblös A, Bacsa S, et al. Expression and functional studies on the noncoding RNA, PRINS［J］. Int J Mol Sci, 2012,14（1）:205⁃225. doi: 10.3390/ijms14010205.
［29］	Sonkoly E, Bata⁃Csorgo Z, Pivarcsi A, et al. Identification and characterization of a novel, psoriasis susceptibility⁃related noncoding RNA gene, PRINS［J］. J Biol Chem, 2005,280（25）:24159⁃24167. doi: 10.1074/jbc.M501704200.
［30］	Szegedi K, Sonkoly E, Nagy N, et al. The anti⁃apoptotic protein G1P3 is overexpressed in psoriasis and regulated by the non⁃coding RNA, PRINS［J］. Exp Dermatol, 2010,19（3）:269⁃278. doi: 10.1111/j.1600⁃0625.2010.01066.x.
［31］	Széll M, Danis J, Bata⁃Csörgö Z, et al. PRINS, a primate⁃specific long non⁃coding RNA, plays a role in the keratinocyte stress response and psoriasis pathogenesis［J］. Pflugers Arch, 2016,468（6）:935⁃943. doi: 10.1007/s00424⁃016⁃1803⁃z.
［32］	Danis J, Göblös A, Bata⁃Csörgö Z, et al. PRINS non⁃coding RNA regulates nucleic acid⁃induced innate immune responses of human keratinocytes［J］. Front Immunol, 2017,8:1053. doi: 10.3389/fimmu.2017.01053.
［33］	Holm SJ, Sánchez F, Carlén LM, et al. HLA⁃Cw*0602 associates more strongly to psoriasis in the Swedish population than variants of the novel 6p21.3 gene PSORS1C3［J］. Acta Derm Venereol, 2005,85（1）:2⁃8. doi: 10.1080/00015550410023527.
［34］	Wu GC, Pan HF, Leng RX, et al. Emerging role of long noncoding RNAs in autoimmune diseases［J］. Autoimmun Rev, 2015,14（9）:798⁃805. doi: 10.1016/j.autrev.2015.05.004.
［35］	Li B, Tsoi LC, Swindell WR, et al. Transcriptome analysis of psoriasis in a large case⁃control sample: RNA⁃seq provides insights into disease mechanisms［J］. J Invest Dermatol, 2014,134（7）:1828⁃1838. doi: 10.1038/jid.2014.28.
［36］	Qiao M, Li R, Zhao X, et al. Up⁃regulated lncRNA⁃MSX2P1 promotes the growth of IL⁃22⁃stimulated keratinocytes by inhibiting miR⁃6731⁃5p and activating S100A7［J］. Exp Cell Res, 2018,363（2）:243⁃254. doi: 10.1016/j.yexcr.2018.01.014.

[1]	Chen Yiwen, Su Ting, Su Zhonglan. Association between psoriasis and STAT3 [J]. Chinese Journal of Dermatology, 2019, 52(7): 502-505.
[2]	Xia Yonghua, Zhang Caifeng, Li Min, Liu Dong, Hu Hua, Zhang Mengjie, Cheng Sai. Effect of downregulation of microRNA-373 expression on cell cycle and apoptosis of a cutaneous squamous cell carcinoma cell line A431 [J]. Chinese Journal of Dermatology, 2019, 52(7): 494-497.
[3]	Su Beibei, Gan Quan, Gan Caibin. Effects of metformin on inflammatory status and phosphorylated Stat3 expression in lesions of a psoriasis?like mouse model [J]. Chinese Journal of Dermatology, 2019, 52(7): 475-480.
[4]	Qin Hui, Zheng Jie. FTY720 ameliorates psoriasis by inhibiting infiltration of skin Interleukin 17-producing γδT cells [J]. Chinese Journal of Dermatology, 2019, 52(6): 395-400.
[5]	Wang Liwei, Luo Lingling, Cui Pan′gen, Li Min. Relationship between intestinal flora and psoriasis [J]. Chinese Journal of Dermatology, 2019, 52(5): 357-360.
[6]	Pan Jiaxu, Zhou Jing. NF?κB signaling pathway in psoriasis [J]. Chinese Journal of Dermatology, 2019, 52(5): 361-363.
[7]	Zeng Jingxin, Tian Xin, Zhu Huilan, Zhang Xibao, Lin Ling, Zhang Lidan, Liu Weiyu, Luo Quan . Expression of miRNA-148a-3p in CD4⁺ T lymphocytes in peripheral blood of patients with psoriasis vulgaris and its clinical significance [J]. Chinese Journal of Dermatology, 2019, 52(4): 231-235.
[8]	Committee on Psoriasis, Chinese Society of Dermatology. Guideline for the diagnosis and treatment of psoriasis in China （2018 simplified edition） [J]. Chinese Journal of Dermatology, 2019, 52(4): 223-230.
[9]	Working Committee on Standardized Diagnosis and Treatment, China Dermatologist Association, Dermatological Surgical Equipment Group and Skin Phototherapy Group, Committee on Skin Disease and Cosmetic Dermatology, China Association of Medical Equipment. Clinical application of home narrow band ultraviolet B phototherapy: an expert consensus statement [J]. Chinese Journal of Dermatology, 2019, 52(3): 156-161.
[10]	Gao Yimeng, Jin Hongzhong. The role of neuropsychiatric factors in the occurrence of psoriasis [J]. Chinese Journal of Dermatology, 2019, 52(3): 204-207.
[11]	Guan Xin, Zhang Chunlei. Evaluation of efficacy of infliximab in the long-term treatment of moderate and severe psoriasis vulgaris [J]. Chinese Journal of Dermatology, 2019, 52(2): 86-89.
[12]	Peng Chen, Chen Wenjuan, Yu Ning, Gao Yunlu, Yi Xuemei, Ding Yangfeng. The progress of relationship between psoriasis and microecology of skin and intestine [J]. Chinese Journal of Dermatology, 2019, 52(2): 135-137.
[13]	WANG Gang. Main adverse reactions in biological agents in dermatology and their strategies [J]. Chinese Journal of Dermatology, 2019, 52(2): 77-80.
[14]	Hu Yu, Luan Chao, Lian Ni, Hao Zhimin, Sun Yujie, Wang Yan, Gu Heng, Chen Min. Expression of proprotein convertase subtilisin/kexin type 9 in the plasma of patients with psoriasis and its effect on the activation of peripheral CD4+ T cells [J]. Chinese Journal of Dermatology, 2019, 52(2): 90-93.
[15]	Xiong Juanjuan, Bi Jianping, Sun Dexiang, Li Nian, Lu Qiaoyun. Dermoscopic features of onychomycosis and nail psoriasis [J]. Chinese Journal of Dermatology, 2019, 52(2): 106-110.

MicroRNA and lncRNA in psoriasis

PDF

Like

Knowledge

Abstract

Cite this article

share this article

References ［36］

Related Articles 15

Metrics

Comments

Recommended 10